Media Mentions
2008
Peter Townshend and George Colindres co-authored an article in BioPharm International, published April 1, entitled, "Trends in Convertible Note Financing for Biotechs." The article discusses the differences between convertible note financings and traditional preferred stock financings, discusses the high stakes of note financings and highlights the complexity of their terms. To view the entire article click here.
George Colindres, Peter N. Townshend, Corporate
2007
Peter Townshend was quoted in the November issue of Entrepreneur Magazine regarding whether the recent viability of IPOs is an indication that boom times from past years have returned. "The market is good--it's not great, [but] it's not frothy," commented Mr. Townshend. He also added, "Good companies that make sense and are meeting their milestones are able to go public and sustain themselves."
Peter N. Townshend was quoted on April 24 by Reuters in an article discussing the trend of accelerated negotiations by private equity firms in the mergers and acquisitions market. In an effort to try and beat opponents in the auction process, private equity bidders are giving high offers and securing the deal well before the bidding deadlines. "The question of whether to take an early bid or go through a complete auction is really a game of chicken for both sides," said Mr. Townshend. "If you go through the whole auction, bidders run the risk that others will outbid them. Meanwhile, if the target completes the whole process and the other offers don't turn out as high as they or Wall Street had expected, the company runs the risk that the early, high bid could disappear," Mr. Townshend added.
Peter N. Townshend, Corporate, Mergers & Acquisitions, Private Equity
